South Korea · Delayed Price · Currency is KRW Narae Nanotech Statistics
Total Valuation
Narae Nanotech has a market cap or net worth of KRW 51.59 billion. The enterprise value is -4.69 billion.
| Market Cap | 51.59B |
| Enterprise Value | -4.69B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Narae Nanotech has 11.06 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 11.06M |
| Shares Outstanding | 11.06M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 49.32% |
| Owned by Institutions (%) | n/a |
| Float | 5.57M |
Valuation Ratios
The trailing PE ratio is 0.90.
| PE Ratio | 0.90 |
| Forward PE | n/a |
| PS Ratio | 0.81 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | 2.37 |
| P/OCF Ratio | 2.27 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.08 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.22 |
Financial Position
The company has a current ratio of 4.64, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.64 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.01 |
| Interest Coverage | -1.72 |
Financial Efficiency
Return on equity (ROE) is 56.63% and return on invested capital (ROIC) is -2.57%.
| Return on Equity (ROE) | 56.63% |
| Return on Assets (ROA) | -1.62% |
| Return on Invested Capital (ROIC) | -2.57% |
| Return on Capital Employed (ROCE) | -3.07% |
| Weighted Average Cost of Capital (WACC) | 11.87% |
| Revenue Per Employee | 420.19M |
| Profits Per Employee | 378.60M |
| Employee Count | 151 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 3.15 |
Taxes
In the past 12 months, Narae Nanotech has paid 14.63 billion in taxes.
| Income Tax | 14.63B |
| Effective Tax Rate | 20.37% |
Stock Price Statistics
The stock price has increased by +52.20% in the last 52 weeks. The beta is 0.74, so Narae Nanotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +52.20% |
| 50-Day Moving Average | 5,427.70 |
| 200-Day Moving Average | 4,108.53 |
| Relative Strength Index (RSI) | 32.86 |
| Average Volume (20 Days) | 35,474 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Narae Nanotech had revenue of KRW 63.45 billion and earned 57.17 billion in profits. Earnings per share was 5,168.85.
| Revenue | 63.45B |
| Gross Profit | 10.61B |
| Operating Income | -4.03B |
| Pretax Income | 71.79B |
| Net Income | 57.17B |
| EBITDA | 1.15B |
| EBIT | -4.03B |
| Earnings Per Share (EPS) | 5,168.85 |
Balance Sheet
The company has 56.44 billion in cash and 161.79 million in debt, with a net cash position of 56.28 billion or 5,089.09 per share.
| Cash & Cash Equivalents | 56.44B |
| Total Debt | 161.79M |
| Net Cash | 56.28B |
| Net Cash Per Share | 5,089.09 |
| Equity (Book Value) | 129.54B |
| Book Value Per Share | 11,713.69 |
| Working Capital | 69.63B |
Cash Flow
In the last 12 months, operating cash flow was 22.69 billion and capital expenditures -932.23 million, giving a free cash flow of 21.76 billion.
| Operating Cash Flow | 22.69B |
| Capital Expenditures | -932.23M |
| Depreciation & Amortization | 5.18B |
| Net Borrowing | -74.18B |
| Free Cash Flow | 21.76B |
| FCF Per Share | 1,967.31 |
Margins
Gross margin is 16.72%, with operating and profit margins of -6.35% and 90.10%.
| Gross Margin | 16.72% |
| Operating Margin | -6.35% |
| Pretax Margin | 113.15% |
| Profit Margin | 90.10% |
| EBITDA Margin | 1.82% |
| EBIT Margin | -6.35% |
| FCF Margin | 34.29% |
Dividends & Yields
Narae Nanotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | 110.81% |
| FCF Yield | 42.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Narae Nanotech has an Altman Z-Score of 2.71 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 5 |